Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Feingold

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The American Journal on Addictions|June 28, 2017
Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD useShaul Lev-Ran, Daniel Feingold, Craig Goodman, et al.
The International Journal on Drug Policy|August 6, 2025
Cannabis trading on Telegram channels: implications for the normalization of use and supplyYifat BenBaruch, Monica J Barratt, Daniel Feingold, et al.
Journal of Dual Diagnosis|November 14, 2014
Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigationShaul Lev-Ran, Daniel Feingold, Alma Frenkel, et al.
Depression and Anxiety|February 28, 2018
Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal studyDaniel Feingold, Jürgen Rehm, Hagai Factor, et al.
Journal of Affective Disorders|July 25, 2016
The association between cannabis use and suicidality among men and women: A population-based longitudinal studyNadav Shalit, Gal Shoval, Dan Shlosberg, et al.
Schizophrenia Research|August 10, 2019
Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort studyIsrael Krieger, Dana Tzur Bitan, Doron Comaneshter, et al.
Journal of Psychosomatic Research|May 18, 2020
Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patientsDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
The Journal of Experimental Biology|July 1, 2016
The orphan pentameric ligand-gated ion channel pHCl-2 is gated by pH and regulates fluid secretion in Drosophila Malpighian tubulesDaniel Feingold, Tanja Starc, Michael J O'Donnell, et al.
Journal of Affective Disorders|April 17, 2018
The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional studyDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
Pain Medicine (Malden, Mass.)|February 17, 2017
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic PainDaniel Feingold, Itay Goor-Aryeh, Silviu Bril, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The American Journal on Addictions|June 28, 2017
Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD useShaul Lev-Ran, Daniel Feingold, Craig Goodman, et al.
The International Journal on Drug Policy|August 6, 2025
Cannabis trading on Telegram channels: implications for the normalization of use and supplyYifat BenBaruch, Monica J Barratt, Daniel Feingold, et al.
Journal of Dual Diagnosis|November 14, 2014
Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigationShaul Lev-Ran, Daniel Feingold, Alma Frenkel, et al.
Depression and Anxiety|February 28, 2018
Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal studyDaniel Feingold, Jürgen Rehm, Hagai Factor, et al.
Journal of Affective Disorders|July 25, 2016
The association between cannabis use and suicidality among men and women: A population-based longitudinal studyNadav Shalit, Gal Shoval, Dan Shlosberg, et al.
Schizophrenia Research|August 10, 2019
Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort studyIsrael Krieger, Dana Tzur Bitan, Doron Comaneshter, et al.
Journal of Psychosomatic Research|May 18, 2020
Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patientsDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
The Journal of Experimental Biology|July 1, 2016
The orphan pentameric ligand-gated ion channel pHCl-2 is gated by pH and regulates fluid secretion in Drosophila Malpighian tubulesDaniel Feingold, Tanja Starc, Michael J O'Donnell, et al.
Journal of Affective Disorders|April 17, 2018
The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional studyDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
Pain Medicine (Malden, Mass.)|February 17, 2017
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic PainDaniel Feingold, Itay Goor-Aryeh, Silviu Bril, et al.
Pageof 8